Labat AfricaJSE:LAB OCF Margin % is 29.75% as of Nov. 2025, which is 3206% above its 10-year median of 0.90. The stock has 5 warning signs investors should review. Among 959 Drug Manufacturers companies, Labat Africa ranks worse than 52.97% on this metric.
The historical rank and industry rank for Labat Africa's OCF Margin % or its related term are showing as below:
JSE:LAB'
s OCF Margin % Range Over the Past 10 Years
Min: -26.52 Med: 0.9 Max: 175.84
Current: 8.6
During the past 13 years, the highest OCF Margin % of Labat Africa was 175.84%. The lowest was -26.52%. And the median was 0.90%.
JSE:LAB's OCF Margin % is ranked worse than 52.97% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.95
vs JSE:LAB: 8.60
Labat Africa OCF Margin % Related Terms
Labat Africa OCF Margin % Historical Data
* Premium members only.
The historical data trend for Labat Africa's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JSE:LAB vs ZTS, UTHR, VTRS: OCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Labat Africa's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Labat Africa OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Labat Africa's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Labat Africa's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Labat Africa (JSE:LAB) has a OCF Margin % of 29.75% as of Nov. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Labat Africa and its competitors. This is 3206% above median its historical median of 0.90. According to the industry distribution chart, Labat Africa ranks #508 out of 959 companies in the Drug Manufacturers industry, placing it in the top 53%.
Is Labat Africa's OCF Margin % too high?
Labat Africa's current OCF Margin % of 29.75% is 3206% above median its 10-year median of 0.90. The Drug Manufacturers industry median OCF Margin % is 9.95. Labat Africa's value of 29.75% is 199% above this industry median. Based on the distribution chart, Labat Africa ranks #508 out of 959 companies in the Drug Manufacturers industry, which is below the industry midpoint.
How does Labat Africa's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Labat Africa ranks #508 out of 959 companies for OCF Margin %. This places Labat Africa in the lower half of its industry. The industry median OCF Margin % is 9.95. Labat Africa's value of 29.75% is 199% above this benchmark. While the company's 10-year median is 0.90 vs. the industry median of 9.95, Labat Africa has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Labat Africa's current OCF Margin % of 29.75% is 199% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Labat Africa and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Labat Africa's current OCF Margin % is 29.75%, which is 3206% above median its own 10-year median of 0.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labat Africa stock overvalued right now?
Based on GuruFocus' analysis, Labat Africa (JSE:LAB) is currently considered Possible Value Trap. The stock's GF Value™ is R0.22, compared to a current price of R0.05 — trading 77.3% below its estimated fair value. The current OCF Margin % is 29.75%, which is 3206% above median its 10-year median of 0.90 and 199% above the Drug Manufacturers industry median of 9.95. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Labat Africa (JSE:LAB), the current OCF Margin % is 29.75% as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Labat Africa Ltd is an investment holding company. Through its subsidiaries, the company operates in the following segments; Technology, Head office, and Healthcare. The Technology segment manufactures and distributes integrated circuits South African Micro - Electronic Systems. Head office operations provide management services, logistics and seeks further investment opportunities for the Group. The Healthcare segment generates maximum revenue for the company and focusses on medical cannabis industry in South Africa. Geographically, the company carries out its business operations in South Africa.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:LAB has been successfully added to your 